Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ro 28-1675 is an effective allosteric GK activator (IC50: 0.24± 0.0019 uM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $726 | 6-8 weeks | |
50 mg | $943 | 6-8 weeks | |
100 mg | $1,420 | 6-8 weeks |
Description | Ro 28-1675 is an effective allosteric GK activator (IC50: 0.24± 0.0019 uM). |
Targets&IC50 | GK:54 nM (EC50) |
In vitro | Ro 28-1675 (50 mg/Kg; p.o.;) treatment to male C57B1/6J mice caused a statistically significant reduction in fasting glucose levels and improvement in glucose tolerance relative to the vehicle-treated animals. Glucokinase activator The R stereoisomer Ro 28-1675 activated GK with an SC1.5 of 0.24 uM, while the S isomer did not activate GK up to 10 uM. A comparison of rat PK parameters indicated that Ro 28-1675 displayed lower clearance and higher oral bioavailability compared to 9a. Ro 28-1675 reduced fasting and postprandial glucose levels following an OGTT following a single oral dose, was well tolerated and displayed no adverse effects related to drug administration other than hypoglycemia at the maximum dose (400 mg) [1] |
Alias | Ro 28-1675 |
Molecular Weight | 378.51 |
Formula | C18H22N2O3S2 |
Cas No. | 300353-13-3 |
Relative Density. | 1.306 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (132.10 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.